Kenneth Bender, PharmD, MA

February 17, 2022

With the physician deficit projected to grow larger within a decade, this global challenge has become a major focus of large organizations and medical societies.

June 18, 2021

With new formulations of effective seizure rescue medications available, epilepsy specialists have begun to refine the approach and education to treating these emergency situations.

May 18, 2021

Acute encephalopathy, coma, and stroke were among clinically diagnosed neurological symptoms that increased mortality risk in patients with COVID-19.

April 27, 2021

Advances in MRI and MRS techniques and protocols enhance diagnosis of neuromuscular disorders and provide prognostic and intervention efficacy biomarkers.

February 18, 2021

Scholz was recognized for her application of advanced genetic techniques to the study of neurodegenerative disorders, including dementia with Lewy bodies, multiple system atrophy, frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration.

August 25, 2020

Efforts to cut through regulatory red tape will help ensure earlier access to potentially lifesaving treatments.

June 23, 2020

New drug classes and formulations may help hold off breakthrough activity as the research community works to optimize levodopa delivery and absorption.

February 26, 2020

The Healey ALS Platform Trial learns from successful cancer drug studies to identify and accelerate new treatments for the devastating disease.

August 29, 2019

Targeting research in cognitive impairment in epilepsy primarily on seizures themselves suggests that a patient’s comorbid problems will resolve with seizure control, though that is not always the case.

July 05, 2019

The neurological symptoms of migraine aura are generally attributed to cortical spreading depression/depolarization, although that hypothesis does have its detractors. The question of whether CSD triggers migraine headache remains controversial.